Overview

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
A study to determine the safety and efficacy of an investigational drug in patients with obesity.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide